Anuh Pharma's Q3 Financial Results Show Mixed Performance, Highest DPS in Industry

Anuh Pharma, a microcap pharmaceutical company, recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO. According to the financial report, Anuh Pharma's performance for the quarter was flat, with a score of -1. However, there has been an improvement from the previous quarter, where the score was -11. One of the positive aspects of Anuh Pharma's financials is its Dividend per Share (DPS), which has been consistently growing each year for the past five years. In fact, the company has the highest DPS at Rs 2.50, indicating that it is distributing higher dividends from its profits. On the other hand, the company's Operating Cash Flow has been declining over the past three years, with the lowest recorded at Rs 12.93 Cr. This suggests that the company's cash revenues from business operations are decreasing. Another concerning factor is the Dividend Payout Ratio (DPR), which is at its lowest in the last five years at 20.86%. This means that the company is distributing a lower proportion of its profits as dividends. Overall, Anuh Pharma's financial performance for the quarter has been mixed, with some positive and negative aspects. Investors should carefully consider these factors before making any investment decisions.